Table 1.
Demographic and clinical details of samples.
| Index |
Gastric carcinoma (n = 22) |
Healthy control (n = 11) |
P-value
(*P <0.05) |
|---|---|---|---|
| Gender (Female, %) | 6 (27.27%) | 7 (63.64%) | |
| Age | 60.59 ± 12.73 | 52.64 ± 10.92 | 0.0866 |
| PG-I (ng/mL) | 80.60 ± 52.66 | 40.35 ± 13.48 | 0.0189* |
| PG-II (ng/mL) | 17.70 ± 9.98 | 7.87 ± 4.73 | 0.0043* |
| PGR (PG- I/ PG-II) | 4.75 ± 1.66 | 5.71 ± 1.63 | 0.1224 |
| AFP (ng/mL) | 49.62 ± 212.38 | 2.33 ± 1.76 | 0.4693 |
| CEA (ng/mL) | 3.92 ± 5.51 | 1.17 ± 0.66 | 0.1121 |
| CA-125 (U/mL) | 7.89 ± 4.74 | 8.20 ± 2.55 | 0.9283 |
| CA-199 (U/mL) | 38.01 ± 75.898 | 10.94 ± 7.14 | 0.3595 |
| ALT (U/L) | 16.05 ± 11.46 | 18.05 ± 8.76 | 0.6143 |
| AST (U/L) | 16.91 ± 6.22 | 18.82 ± 4.52 | 0.3737 |
| Total bilirubin (μmol/L) | 8.76 ± 3.71 | 12.97 ± 3.68 | 0.0206* |
| Total protein (g/L) | 58.77 ± 12.76 | 73.42 ± 4.31 | 0.0110* |
| Globulin (g/L) | 22.83 ± 3.41 | 28.97 ± 3.31 | 0.0006* |
| Albumin to globulin ratio | 1.72 ± 0.28 | 1.56 ± 0.17 | 0.2818 |
| Total bile acid (μmol/L) | 7.26 ± 8.018 | 1.93 ± 0.79 | 0.2030 |
| Glucose (mmol/L) | 5.03 ± 1.44 | 5.03 ± 0.51 | 0.9928 |
| Urea (mmol/L) | 5.77 ± 2.12 | 5.52 ± 0.99 | 0.7098 |
| Creatinine (μmol/L) | 69.50 ± 17.22 | 65.36 ± 11.24 | 0.4765 |
| Uric acid (μmol/L) | 302.45 ± 77.20 | 318.73 ± 58.90 | 0.5349 |
| Triglycerides (mmol/L) | 1.58 ± 1.06 | 1.05 ± 0.54 | 0.1318 |
| Cholesterol (mmol/L) | 4.18 ± 0.77 | 5.24 ± 0.61 | 0.0004* |
| H-cholesterol (mmol/L) | 1.13 ± 0.31 | 4.59 ± 0.39 | 0.0009* |
| L-cholesterol (mmol/L) | 2.41 ± 0.67 | 3.11 ± 0.48 | 0.0043* |
| CRP (mg/L) | 4.26 ± 2.03 | 4.45 ± 4.98 | 0.8933 |